Matthias Fischer Selected Research

Airway Management

1/2023	Effect of video laryngoscopy for non-trauma out-of-hospital cardiac arrest on clinical outcome: A registry-based analysis.
1/2020	Effect of airway management strategies during resuscitation from out-of-hospital cardiac arrest on clinical outcome: A registry-based analysis.
6/2015	Difficult intubation and outcome after out-of-hospital cardiac arrest: a registry-based analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthias Fischer Research Topics

Disease

85	Neuroblastoma 01/2024 - 07/2004
61	Neoplasms (Cancer) 01/2024 - 07/2004
22	Out-of-Hospital Cardiac Arrest 11/2023 - 01/2007
17	Heart Arrest (Cardiac Arrest) 06/2024 - 09/2002
7	Wounds and Injuries (Trauma) 10/2022 - 04/2007
4	Anaphylaxis (Anaphylactic Shock) 01/2021 - 01/2018
4	Hypoxia (Hypoxemia) 12/2020 - 07/2011
4	Carcinogenesis 11/2019 - 01/2009
4	Ventricular Fibrillation 10/2004 - 09/2002
3	Hemorrhage 12/2020 - 02/2009
2	Shock 10/2022 - 10/2019
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2021 - 01/2016
2	Rhabdomyosarcoma 12/2021 - 01/2016
2	Parakeratosis 02/2021 - 09/2004
2	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2021 - 09/2004
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 05/2019
2	Acute Coronary Syndrome 10/2019 - 03/2014
2	Body Weight (Weight, Body) 11/2017 - 01/2007
2	Disease Progression 10/2017 - 10/2015
2	Cardiogenic Shock 03/2016 - 03/2014
2	Skin Diseases (Skin Disease) 02/2009 - 09/2004
1	Craniocerebral Trauma (Head Injury) 10/2022
1	COVID-19 01/2022
1	Chromothripsis 12/2021
1	Blepharitis 02/2021
1	Birdshot Chorioretinopathy 02/2021
1	Atrophy 02/2021
1	Corneal Perforation 02/2021
1	Pityriasis Lichenoides (Pityriasis Lichenoides et Varioliformis Acuta) 02/2021
1	Pachyonychia Congenita (Jadassohn-Lewandowsky Syndrome) 02/2021
1	Trichiasis 02/2021
1	Entropion 02/2021
1	Ectropion 02/2021
1	Ichthyosis (Xeroderma) 02/2021
1	Retinal Neovascularization 02/2021
1	Conjunctivitis 02/2021
1	Uveitis 02/2021
1	Leukoplakia 02/2021
1	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 02/2021
1	Keratitis 02/2021
1	Scleritis (Episcleritis) 02/2021
1	Pityriasis Rubra Pilaris 02/2021
1	Darier Disease (Darier's Disease) 02/2021

Drug/Important Bio-Agent (IBA)

11	Messenger RNA (mRNA)IBA 04/2022 - 02/2005
10	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2024 - 10/2012
10	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2014
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2007
7	Long Noncoding RNAIBA 01/2024 - 11/2014
6	Biomarkers (Surrogate Marker)IBA 12/2019 - 11/2014
5	Epinephrine (Adrenaline)FDA LinkGeneric 03/2023 - 01/2007
5	Anaplastic Lymphoma KinaseIBA 01/2023 - 08/2011
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2022 - 04/2011
5	RNA (Ribonucleic Acid)IBA 01/2021 - 07/2009
5	OligonucleotidesIBA 12/2019 - 11/2006
5	N-Myc Proto-Oncogene ProteinIBA 12/2019 - 05/2010
4	ChromatinIBA 01/2019 - 10/2008
4	MicroRNAs (MicroRNA)IBA 12/2018 - 11/2012
3	Adrenergic Agents (Adrenergic Drugs)IBA 01/2023 - 11/2012
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 02/2016
3	Histone Deacetylase InhibitorsIBA 01/2019 - 01/2009
3	Complementary DNA (cDNA)IBA 12/2007 - 01/2006
2	NucleotidesIBA 01/2023 - 07/2021
2	alpha-2'-deoxythioguanosineIBA 10/2022 - 12/2019
2	ceritinibIBA 10/2022 - 12/2021
2	MYCN inhibitor BGA002IBA 04/2022 - 12/2019
2	InterferonsIBA 01/2021 - 01/2017
2	ChemokinesIBA 01/2021 - 01/2017
2	Cell-Free Nucleic AcidsIBA 11/2020 - 10/2017
2	Circular DNAIBA 04/2020 - 01/2020
2	Oncogene Proteins (Oncogene Protein)IBA 11/2019 - 11/2019
2	HomocysteineIBA 11/2017 - 03/2006
2	BI 2536IBA 01/2017 - 02/2011
2	Polo-Like Kinase 1IBA 01/2017 - 02/2011
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2017 - 01/2009
2	Decitabine FDA Link 02/2016 - 12/2014
2	AutoantibodiesIBA 01/2016 - 07/2012
2	Folic Acid (Vitamin M)FDA LinkGeneric 06/2015 - 03/2006
2	AntigensIBA 07/2012 - 07/2004
1	SelenocysteineIBA 01/2023
1	Selenoprotein PIBA 01/2023
1	imetelstatIBA 10/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2022
1	Etoposide (VP 16)FDA LinkGeneric 10/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 07/2022
1	Cystine (L-Cystine)IBA 01/2022
1	Cysteine (L-Cysteine)FDA Link 01/2022
1	Retinaldehyde (Retinal)IBA 02/2021

Therapy/Procedure

34	Therapeutics 01/2023 - 10/2004
25	Resuscitation 06/2024 - 04/2007
21	Cardiopulmonary Resuscitation (CPR) 03/2023 - 09/2002
5	Drug Therapy (Chemotherapy) 10/2022 - 04/2015
3	Airway Management 01/2023 - 06/2015
3	Extracorporeal Membrane Oxygenation 03/2016 - 03/2014
3	Percutaneous Coronary Intervention 03/2014 - 05/2010
2	Investigational Therapies (Experimental Therapy) 10/2021 - 01/2020
2	Critical Care (Surgical Intensive Care) 01/2021 - 02/2009
2	Combined Modality Therapy 10/2016 - 10/2015
2	Microspheres (Microsphere) 03/2003 - 09/2002
1	Blood Transfusion (Blood Transfusions) 10/2022